AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Lexaria Bioscience Corp. Director's Dealing 2015

Apr 15, 2015

34983_dirs_2015-04-15_a3959d23-f795-42a4-8321-aa39be8ded16.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2010-01-20

Reporting Person: BUNKA CHRISTOPHER (Director, CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-04-13	Common Shares	P	25000	$0.1	Acquired	3273794	Direct
2015-04-13	Common Shares	P	10000	$0.103	Acquired	3283794	Direct
2015-04-14	Common Shares	P	35000	$0.102	Acquired	3318794	Direct
2015-04-15	Common Shares	P	45000	$0.103	Acquired	3363794	Direct
2015-04-15	Common Shares	P	50000	$0.13	Acquired	3413794	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	4318958	Indirect
Common Shares	3248794	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$0.11	2019-12-23	Common Shares (500000)	500000	Direct
Stock Options	$0.35	2016-07-11	Common Shares (200000)	700000	Direct
Stock Options	$0.1	2018-06-18	Common Shares (225000)	925000	Direct
Warrants	$0.25	2015-09-21	Common Shares (100067)	1025067	Direct

Footnotes

F1: Purchase price is in Canadian dollars.